Review Article
Targeting Insulin and Insulin-Like Growth Factor Pathways in Epithelial Ovarian Cancer
Table 3
Circulating protein levels of the insulin/IGF system in ovarian cancer.
| Insulin/IGF components | No. of patients | Modulation | Reference |
| IGFBP-2 | 20 EOC | | [49] | IGF-I | 58 EOC | | [53] | IGF-I | 24 EOC | | [52] | IGF-I | 59 EOC | | [54] | IGF-I | 9 EOC | | [55] | IGF-I | 132 EOC (<55 yrs.) | | [56] | IGF-I | 214 EOC (<55 yrs.) | | [57] | IGF-I, IGFBP-2, IGFBP-3 | 222 EOC | | [58] |
|
|
EOC: epithelial ovarian cancer.
|